Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Immuneering Corp changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 38 | 42 | +4 |
| Shares | 4.36M | 4.30M | −52.9K (−1.2%) |
| Value | $10.9M | $9.32M | −$1.55M (−14.2%) |
New holders (7)
Institutions that held Immuneering Corp at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rockefeller Capital Management L.P. | 177,377 | $390.2K | 0.00% |
| First Manhattan Co | 32,325 | $71.1K | 0.00% |
| Marshall Wace, LLP | 21,432 | $47.1K | 0.00% |
| Tang Capital Management LLC | 12,073 | $26.6K | 0.00% |
| JustInvest LLC | 11,705 | $25.8K | 0.00% |
| BNP Paribas Arbitrage, SA | 349 | $768 | 0.00% |
| SBI Securities Co., Ltd. | 74 | $163 | 0.00% |
Sold out (3)
Institutions that held Immuneering Corp at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Prosight Management, LP | 190,000 | $473.1K |
| Qube Research & Technologies Ltd | 14,823 | $36.9K |
| Royal Bank of Canada | 11,294 | $28.0K |